Bleeding and clotting cases following Covid-19 vaccination in India are minuscule but definitive and in line with the expected number of such diagnoses, a report submitted by the national committee on the Adverse Effects Following Immunisation (AEFI) on Monday said.
The government decided to conduct an in-depth analysis of adverse events in India in light of global concerns, the health ministry said. Some countries on March 11 raised an alert on post-vaccination embolic and thrombotic events, particularly with AstraZeneca-Oxford vaccine — Covishield in India, the ministry said.
The reporting rate of these events in India is around 0.61 per million doses, lower